PHOTOSENSITIZING AGENTS MEDICAL APPLICATIONS

Brand Owner (click to sort) Address Description
SOLACIN ONDINE INTERNATIONAL HOLDINGS, LTD. Edghill House #5, Wildey Business Park St. Michael Barbados PHOTOSENSITIZING AGENTS FOR MEDICAL APPLICATIONS, NAMELY, PHARMACEUTICALS FOR THE TREATMENT OF INFECTIOUS DISEASES; LIGHT-ACTIVATED DISINFECTANT COMPOSITIONS FOR KILLING DISEASE-CAUSING MICRO-ORGANISMS; LIGHT-ACTIVATED THERAPEUTIC PREPARATIONS FOR KILLING BACTERIAL, FUNGAL AND VIRAL INFECTIONS; PHOTOSENSITIZERS FOR USE IN PHOTODYNAMIC THERAPY AND/OR PHOTODISINFECTION, NAMELY, PHARMACEUTICALS FOR THE TREATMENT OF INFECTIOUS DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STAPH INFECTIONS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF METHICILLIN-RESISTANT STAPH INFECTIONS;MEDICAL EQUIPMENT, NAMELY, LASERS, LED, INCANDESCENT LIGHTS, FLUORESCENT LIGHTS, STERILIZABLE LIGHT WANDS, SENSORY LIGHT THERAPY UNIT FOR USE IN FIELD OF PHOTODYNAMIC THERAPY AND/OR PHOTODISINFECTION; A LIGHT DELIVERY DEVICE, NAMELY, LASERS, LED, INCANDESCENT LIGHTS, FLUORESCENT LIGHTS, STERILIZABLE LIGHT WANDS, SENSORY LIGHT THERAPY UNIT FOR USE IN TREATMENT OF STAPH INFECTION; A LIGHT DELIVERY DEVICE, NAMELY, LASERS, LED, INCANDESCENT LIGHTS, FLUORESCENT LIGHTS, STERILIZABLE LIGHT WANDS, SENSORY LIGHT THERAPY UNIT FOR USE IN TREATMENT OF METHICILLIN-RESISTANT STAPH INFECTION; OPTIC PROBE TIPS, MEDICAL SYRINGES AND AEROSOL DISPENSER FOR MEDICAL USE IN PHOTODYNAMIC THERAPY AND/OR PHOTODISINFECTION;
SOLACIN ONDINE INTERNATIONAL HOLDINGS, LTD. Edghill House #5, Wildey Business Park St. Michael Barbados Photosensitizing agents for medical applications, namely, pharmaceuticals for photodynamic therapy and/or photo disinfection; light-activated disinfectant compositions for killing disease-causing micro-organisms; light activated photosensitizing compositions for killing tumor cells;
SOLACIN ONDINE INTERNATIONAL HOLDINGS, LTD. Edghill House #5, Wildey Business Park St. Michael Barbados Photosensitizing agents for medical applications, namely, pharmaceuticals for photodynamic therapy and/or photo disinfection for the treatment of topical microbial infections, inflammatory diseases, periodontitis, sinusitis including chronic sinusitis, otitis media and externa, deep surgical incisions, orthopedic implants, and wounds; light-activated disinfectant compositions for killing disease-causing micro-organisms, namely, disinfectants for medical instruments and components, medical devices and catheters, and disinfectants for sanitary purposes; tumor suppressing agents, namely, light activated photosensitizing compositions for killing tumor cells;
SOLACIN ONDINE INTERNATIONAL AG C/O CONFIDARIS AG OBERWILER KIRCHWEG 4A 6300 ZUG Switzerland Photosensitizing agents for medical applications, namely, pharmaceuticals for photodynamic therapy and/or photo disinfection for the treatment of topical microbial infections, inflammatory diseases, periodontitis, sinusitis including chronic sinusitis, otitis media and externa, deep surgical incisions, orthopedic implants, and wounds; light-activated disinfectant compositions for killing disease-causing micro-organisms, namely, disinfectants for medical instruments and components, medical devices and catheters, and disinfectants for sanitary purposes; tumor suppressing agents, namely, light activated photosensitizing compositions for killing tumor cells;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. In addition to reducing or substantially eliminating a biological organism's reaction to the introduction of the medical device to the organism, the medical device in combination with one or more therapeutic drugs, agents and/or compounds may be utilized to treat various vascular diseases, for example, restenosis and vulnerable plaque. In the case of vulnerable plaque, one or more drugs, agents or compounds may be utilized to treat the various aspects of vulnerable plaque and these drugs, agents and/or compounds may be released with a given release profile for the most effective treatment. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.